Apoptosis Assays Market Research Report - Forecast till 2027

Apoptosis Assays Market Research Report: By Product (Kits, Instruments), by Detection Technology (Flow Cytometry, Microscopy), by Application (Drug Discovery and Development), and by End User (Pharmaceutical and Biological, Hospital) - Forecast till 2027

ID: MRFR/LS/5335-HCR | February 2021 | Region: Global | 100 pages

Apoptosis Assays Market Scenario:


The apoptosis assays market is expected to grow significantly over the forecast period. The market held a value of USD 2.99 billion in 2017 and is projected to register a CAGR of 9.4% over the forecast period.


Factors such as increasing R&D expense, growing cell-based research, and growing funding for cancer research are expected to propel the growth of the market. However, required high investment for research activities is likely to hamper the market growth over the forecast period. Recently, the National Institutes of Health (NIH) invested USD 1.65 billion for stem cell research in 2017.


Segmentation:


The apoptosis assays market has been segmented into product, detection technology, application, and end user.


Based on product, the apoptosis assays market is segmented into kits, reagents, instruments, and others. The kits segment accounted for the largest share segment of the market in 2017.


Based on detection technology, the apoptosis assays market is segmented into flow cytometry, fluorescence microscopy, western blot assessment, gel electrophoresis, and others.


Based on application, the apoptosis assays market is segmented into drug discovery and development, stem cell research, and others.


Based on end user, the apoptosis assays market is segmented into pharmaceutical and biological companies, research institutes, and others.


The apoptosis assays market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The apoptosis assays market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.


The European apoptosis assays market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.


The apoptosis assays market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The apoptosis assays market in the Middle East and Africa has been segmented into the Middle East and Africa.


Regional Market Summary


Geographically, the Americas is anticipated to dominate the global apoptosis assays market owing to well-established players and increasing R&D expenses.


Europe is expected to hold the second largest position in the global apoptosis assays market. The market growth in this region is attributed to the growth in the pharmaceutical and biotech industry.


The apoptosis assays market in the Asia-Pacific region consists of countries, namely, China, Japan, the Republic of Korea, India, Australia, and the Rest of Asia-Pacific. The Asia-Pacific region is expected to be the fastest growing region. The Middle East and Africa has the least share of the market.

Global Apoptosis Assays Market Share (%), by Region, 2017


Source: Annual Reports and Sec filings


Key players:


Abcom plc, Merck KGaA (Germany), Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), GE Healthcare (US), Danaher Corporation (US), Becton, Dickinson and Company (US), Sartorius AG (Germany), Geno Technology (US), GeneCopoeia, Inc. (US), and Promega Corporation (US) are some of the key players in the apoptosis assays market.


Intended Audience



  • Apoptosis assays products manufacturers and vendors

  • Pharmaceutical and biotech companies

  • Contract research organizations

  • Various research and consulting firms


Apoptosis Assays Market, by Product



  • Kits

  • Reagents

  • Instruments

  • Others


Apoptosis Assays Market, by Detection Technology



  • Flow Cytometry

  • Fluorescence Microscopy

  • Western Blot Assessment

  • Gel Electrophoresis

  • Others


Apoptosis Assays Market, by Application



  • Drug Discovery and Development

  • Stem Cell Research

  • Others


Apoptosis Assays Market, by End User



  • Pharmaceutical and Biological Companies

  • Research Institutes

  • Others


Apoptosis assays Market, by Region



  • Americas

    • North America

      • US

      • Canada



    • South America



  • Europe

    • Western Europe

      • Germany

      • France

      • Italy

      • Spain

      • UK

      • Rest of Western Europe



    • Eastern Europe



  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific



  •  Middle East & Africa

    • Middle East

    • Africa





Report Scope:
Report Attribute/Metric Details
  Market Size

  • 2017: USD 2.99 Billion
  • 2027: Significant Value
  •   CAGR   9.4% (2017-2023)
      Base Year   2019
      Forecast Period   2020-2027
      Historical Data   2018
      Forecast Units   Value (USD Billion)
      Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
      Segments Covered   Product, Detection Technology, Application, End User
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors   Abcom plc, Merck KGaA (Germany), Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), GE Healthcare (US), Danaher Corporation (US), Becton, Dickinson and Company (US), Sartorius AG (Germany), Geno Technology (US), GeneCopoeia, Inc. (US), and Promega Corporation (US)
      Key Market Opportunities   New product launches and R&D Amongst major key Players
      Key Market Drivers

  • Increasing R&D expense
  • Growing cell-based research Growing funding for cancer research


  • Frequently Asked Questions (FAQ) :


    The apoptosis assays market is projected to grow at a 9.4% CAGR between 2018-2023.

    The Americas is projected to command the largest share in the apoptosis assays market.

    Major applications of apoptosis assays include stem cell research and drug discovery development.

    Growing funds for cancer research are boosting market growth.

    Required high investment for research activities may limit market growth.

    Table of Contents:

    Chapter 1. Report Prologue

    Chapter 2. Market Introduction

    2.1 Definition

    2.2 Scope of the Study

    2.2.1 Research Objective

    2.2.2 Assumptions

    2.2.3 Limitations

    Chapter 3. Research Methodology

    3.1 Introduction

    3.2 Primary Research

    3.3 Secondary Research

    3.4 Market Size Estimation

    Chapter 4. Market Dynamics

    4.1 Drivers

    4.2 Restraints

    4.3 Opportunities

    4.4 Challenges

    4.5 Macroeconomic Indicators

    4.6 Detection Technology Trends & Assessment

    Chapter 5. Market Factor Analysis

    5.1 Porter’s Five Forces Analysis

    5.1.1 Bargaining Power of Suppliers

    5.1.2 Bargaining Power of Buyers

    5.1.3 Threat of New Entrants

    5.1.4 Threat of Substitutes

    5.1.5 Intensity of Rivalry

    5.2 Value Chain Analysis

    5.3 Investment Feasibility Analysis

    Chapter 6. Global Apoptosis Assays Market, by Product

    6.1 Introduction

    6.2 Kits

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.3 Reagents

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.4 Instruments

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.4 Others

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    Chapter 7. Global Apoptosis Assays Market, by Detection Technology

    7.1 Introduction

    7.2 Flow Cytometry

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7.3 Fluorescence Microscopy

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7.4 Western Blot Assessment

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7.5 Gel Electrophoresis

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7.6 Others

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    Chapter 8. Global Apoptosis Assays Market, by Application

    8.1 Introduction

    8.2 Drug Discovery And Development

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.3 Stem Cell Research

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.4 Others

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    Chapter 9. Global Apoptosis Assays Market, by End User

    9.1 Introduction

    9.2 Pharmaceutical And Biological Companies

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    9.3 Research Institutes

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    9.4 Others

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    Chapter 10. Global Apoptosis Assays Market, by Region

    10.1 Introduction

    10.2 Americas

    10.2.1 North America

    10.2.1.1 US

    10.2.1.2 Canada

    10.2.2 South America

    10.3 Europe

    10.3.1 Western Europe

    10.3.1.1 Germany

    10.3.1.2 France

    10.3.1.3 Italy

    10.3.1.4 Spain

    10.3.1.5 UK

    10.3.1.6 Rest of Western Europe

    10.3.2 Eastern Europe

    10.4 Asia-Pacific

    10.4.1 Japan

    10.4.2 China

    10.4.3 India

    10.4.4 Australia

    10.4.5 South Korea

    10.4.6 Rest of Asia-Pacific

    10.5 Middle East & Africa

    10.5.1 Middle East

    10.5.2 Africa

    Chapter 11. Company Landscape

    11.1 Introduction

    11.2 Market Share Analysis

    11.3 Key Development & Strategies

    Chapter 12. Company Profiles

    12.1 Abcom plc

    12.1.1 Company Overview

    12.1.2 Product Overview

    12.1.3 Financials Overview

    12.1.4 Key Developments

    12.1.5 SWOT Analysis

    12.2 Merck KGaA

    12.2.1 Company Overview

    12.2.2 Product Overview

    12.2.3 Financial Overview

    12.2.4 Key Developments

    12.2.5 SWOT Analysis

    12.3 Bio-Rad Laboratories

    12.3.1 Company Overview

    12.3.2 Product Overview

    12.3.3 Financial Overview

    12.3.4 Key Development

    12.3.5 SWOT Analysis

    12.4 GE Healthcare

    12.4.1 Company Overview

    12.4.2 Product Overview

    12.4.3 Financial Overview

    12.4.4 Key Development

    12.4.5 SWOT Analysis

    12.5 Danaher Corporation

    12.5.1 Company Overview

    12.5.2 Product Overview

    12.5.3 Financial overview

    12.5.4 Key Developments

    12.5.5 SWOT Analysis

    12.6 Becton, Dickinson and Company

    12.6.1 Company Overview

    12.6.2 Product Overview

    12.6.3 Financial Overview

    12.6.4 Key Developments

    12.6.5 SWOT Analysis

    12.7 Sartorius AG

    12.7.1 Overview

    12.7.2 Product Overview

    12.7.3 Financial Overview

    12.7.4 Key Developments

    12.7.5 SWOT Analysis

    12.8 Geno Technology

    12.8.1 Overview

    12.8.2 Product Overview

    12.8.3 Financials

    12.8.4 Key Developments

    12.8.5 SWOT Analysis

    12.9 Promega Corporation

    12.9.1 Overview

    12.9.2 Product Overview

    12.9.3 Financials

    12.9.4 Key Developments

    12.9.5 SWOT Analysis

    12.12 Thermo Fisher Scientific Inc.

    12.10.1 Overview

    12.10.2 Product Overview

    12.10.3 Financials

    12.10.4 Key Developments

    12.10.5 SWOT Analysis

    12.11 Others

    Chapter 13 MRFR Conclusion

    13.1 Key Findings

    13.1.1 From CEO’s Viewpoint

    13.1.2 Unmet Needs of the Market

    13.2 Key Companies to Watch

    13.3 Predictions for the Apoptosis Assays Industry

    Chapter 14. Appendix

    LIST OF TABLES

    Table 1 Global Apoptosis Assays Market Synopsis, 2020-2027

    Table 2 Global Apoptosis Assays Market Estimates and Forecast, 2020-2027 (USD Million)

    Table 3 Global Apoptosis Assays Market, by Region, 2020-2027 (USD Million)

    Table 4 Global Apoptosis Assays Market, by Product, 2020-2027 (USD Million)

    Table 5 Global Apoptosis Assays Market, by Detection Technology, 2020-2027 (USD Million)

    Table 6 Global Apoptosis Assays Market, by Application, 2020-2027 (USD Million)

    Table 7 Global Apoptosis Assays Market, by End User, 2020-2027 (USD Million)

    Table 8 North America: Apoptosis Assays Market, by Product, 2020-2027 (USD Million)

    Table 9 North America: Apoptosis Assays Market, by Detection Technology, 2020-2027 (USD Million)

    Table 10 North America: Apoptosis Assays Market, by Application, 2020-2027 (USD Million)

    Table 11 North America: Apoptosis Assays Market, by End User, 2020-2027 (USD Million)

    Table 12 US: Apoptosis Assays Market, by Product, 2020-2027 (USD Million)

    Table 13 US: Apoptosis Assays Market, by Detection Technology, 2020-2027 (USD Million)

    Table 14 US: Apoptosis Assays Market, by Application, 2020-2027 (USD Million)

    Table 15 US: Apoptosis Assays Market, by End User, 2020-2027 (USD Million)

    Table 16 Canada: Apoptosis Assays Market, by Product, 2020-2027 (USD Million)

    Table 17 Canada: Apoptosis Assays Market, by Detection Technology, 2020-2027 (USD Million)

    Table 18 Canada: Apoptosis Assays Market, by Application, 2020-2027 (USD Million)

    Table 19 Canada: Apoptosis Assays Market, by End User, 2020-2027 (USD Million)

    Table 20 South America: Apoptosis Assays Market, by Product, 2020-2027 (USD Million)

    Table 21 South America: Apoptosis Assays Market, by Detection Technology, 2020-2027 (USD Million)

    Table 22 South America: Apoptosis Assays Market, by Application, 2020-2027 (USD Million)

    Table 23 South America: Apoptosis Assays Market, by End User, 2020-2027 (USD Million)

    Table 24 Europe: Apoptosis Assays Market, by Product, 2020-2027 (USD Million)

    Table 25 Europe: Apoptosis Assays Market, by Detection Technology, 2020-2027 (USD Million)

    Table 26 Europe: Apoptosis Assays Market, by Application, 2020-2027 (USD Million)

    Table 27 Europe: Apoptosis Assays Market, by End User, 2020-2027 (USD Million)

    Table 28 Western Europe: Apoptosis Assays Market, by Product, 2020-2027 (USD Million)

    Table 29 Western Europe: Apoptosis Assays Market, by Detection Technology, 2020-2027

    (USD Million)

    Table 30 Western Europe: Apoptosis Assays Market, by Application, 2020-2027 (USD Million)

    Table 31 Western Europe: Apoptosis Assays Market, by End User, 2020-2027 (USD Million)

    Table 32 Eastern Europe: Apoptosis Assays Market, by Product, 2020-2027 (USD Million)

    Table 33 Eastern Europe: Apoptosis Assays Market, by Detection Technology, 2020-2027 (USD Million)

    Table 34 Eastern Europe: Apoptosis Assays Market, by Application, 2020-2027 (USD Million)

    Table 35 Eastern Europe: Apoptosis Assays Market, by End User, 2020-2027 (USD Million)

    Table 36 Asia-Pacific: Apoptosis Assays Market, by Product, 2020-2027 (USD Million)

    Table 37 Asia-Pacific: Apoptosis Assays Market, by Detection Technology, 2020-2027 (USD Million)

    Table 38 Asia-Pacific: Apoptosis Assays Market, by Application, 2020-2027 (USD Million)

    Table 39 Asia-Pacific: Apoptosis Assays Market, by End User, 2020-2027 (USD Million)

    Table 40 Middle East & Africa: Apoptosis Assays Market, by Product, 2020-2027

    (USD Million)

    Table 41 Middle East & Africa: Apoptosis Assays Market, by Detection Technology, 2020-2027

    (USD Million)

    Table 42 Middle East & Africa: Apoptosis Assays Market, by Application, 2020–

    2027 (USD Million)

    Table 43 Middle East & Africa: Apoptosis Assays Market, by End User, 2020–

    2027 (USD Million)

    LIST OF FIGURES

    Figure 1 Research Process

    Figure 2 Global Apoptosis Assays Market

    Figure 3 Market Dynamics for Global Apoptosis Assays Market

    Figure 4 Global Apoptosis Assays Market Share, by Product, 2020

    Figure 5 Global Apoptosis Assays Market Share, by Detection Technology, 2020

    Figure 6 Global Apoptosis Assays Market Share, by Application, 2020

    Figure 7 Global Apoptosis Assays Market Share, by End User, 2020

    Figure 8 Global Apoptosis Assays Market Share, by Region, 2020

    Figure 9 North America: Apoptosis Assays Market Share, by Country, 2020

    Figure 10 Europe: Apoptosis Assays Market Share, by Country, 2020

    Figure 11 Asia-Pacific: Apoptosis Assays Market Share, by Country, 2020

    Figure 12 Middle East & Africa: Apoptosis Assays Market Share, by Country, 2020

    Figure 13 Global Apoptosis Assays Market: Company Share Analysis, 2020 (%)

    Figure 14 Abcom plc: Key Financials

    Figure 15 Abcom plc: Segmental Revenue

    Figure 16 Abcom plc: Geographical Revenue

    Figure 17 Merck KGaA: Key Financials

    Figure 18 Merck KGaA: Segmental Revenue

    Figure 19 Merck KGaA: Geographical Revenue

    Figure 20 Bio-Rad Laboratories: Key Financials

    Figure 21 Bio-Rad Laboratories: Segmental Revenue

    Figure 22 Bio-Rad Laboratories: Geographical Revenue

    Figure 23 GE Healthcare: Key Financials

    Figure 24 GE Healthcare: Segmental Revenue

    Figure 25 GE Healthcare: Geographical Revenue

    Figure 26 DANAHER CORPORATION: Key Financials

    Figure 27 DANAHER CORPORATION: Segmental Revenue

    Figure 28 DANAHER CORPORATION. Geographical Revenue

    Figure 29 Becton, Dickinson and Company: Key Financials

    Figure 30 Becton, Dickinson and Company: Segmental Revenue

    Figure 31 Becton, Dickinson and Company: Geographical Revenue

    Figure 32 Sartorius AG: Key Financials

    Figure 33 Sartorius AG: Segmental Revenue

    Figure 34 Sartorius AG: Geographical Revenue

    Figure 35 Geno Technology: Key Financials

    Figure 36 Geno Technology: Segmental Revenue

    Figure 37 Geno Technology: Geographical Revenue

    Figure 38 Thermo Fisher Scientific Inc: Key Financials

    Figure 39 Thermo Fisher Scientific Inc: Segmental Revenue

    Figure 40 Thermo Fisher Scientific Inc: Geographical Revenue

    Figure 41 Promega Corporation: Key Financials

    Figure 42 Promega Corporation: Segmental Revenue

    Figure 43 Promega Corporation: Geographical Revenue